Zhang S - Search Results

1

The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment.

Zhang T, Lv H, Li J, Zhang S, Zhang J, Wang S, Wang Y, Guo Z. Zhang T, et al. Among authors: zhang s, zhang j. Front Immunol. 2024 Dec 24;15:1503316. doi: 10.3389/fimmu.2024.1503316. eCollection 2024. Front Immunol. 2024. PMID: 39776906 Free PMC article.

2

Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients.

Liu J, Ma J, Xing N, Ji Z, Li J, Zhang S, Guo Z. Liu J, et al. Among authors: zhang s. J Cancer Res Clin Oncol. 2023 Jul;149(7):3043-3050. doi: 10.1007/s00432-022-04201-z. Epub 2022 Jul 19. J Cancer Res Clin Oncol. 2023. PMID: 35852620

3

Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients.

Zhao Y, Ji Z, Li J, Zhang S, Wu C, Zhang R, Guo Z. Zhao Y, et al. Among authors: zhang r, zhang s. Front Oncol. 2022 Aug 9;12:917313. doi: 10.3389/fonc.2022.917313. eCollection 2022. Front Oncol. 2022. PMID: 36016614 Free PMC article.

4

Pulmonary Arterial Hypertension Induced by Immune Checkpoint Inhibitor Combined Therapy in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report.

Zhang J, Zhang S, Xu S, Zhang X, Li J, Ji Z, Liu Q, Guo Z. Zhang J, et al. Among authors: zhang s, zhang x. Iran J Immunol. 2023 May 31;20(2):240-246. doi: 10.22034/iji.2023.96898.2464. Epub 2023 May 14. Iran J Immunol. 2023. PMID: 37179468 Free article.

5

Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers.

Wang Y, Zhang S, Zhang F, Wang L, Wu C, Zhang X, Zhang R, Guo Z. Wang Y, et al. Among authors: zhang r, zhang s, zhang f, zhang x. Front Oncol. 2023 May 3;13:1155019. doi: 10.3389/fonc.2023.1155019. eCollection 2023. Front Oncol. 2023. PMID: 37207161 Free PMC article.

6

Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.

Zhang J, Wang L, Zhang S, Cao R, Zhao Y, Zhao Y, Song Y, Guo Z. Zhang J, et al. Among authors: zhang s. BMC Cancer. 2024 Feb 26;24(1):266. doi: 10.1186/s12885-024-11999-z. BMC Cancer. 2024. PMID: 38408930 Free PMC article.

7

Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.

Li J, Ding F, Zhang S, Jia Y, Zhang T, Wang S, Liu Q, Guo Z. Li J, et al. Among authors: zhang s, zhang t. BMC Cancer. 2024 Oct 18;24(1):1292. doi: 10.1186/s12885-024-13063-2. BMC Cancer. 2024. PMID: 39425079 Free PMC article.

8

The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients.

Ji Z, Li J, Zhang S, Jia Y, Zhang J, Guo Z. Ji Z, et al. Among authors: zhang s, zhang j. Front Immunol. 2024 Nov 27;15:1480520. doi: 10.3389/fimmu.2024.1480520. eCollection 2024. Front Immunol. 2024. PMID: 39664382 Free PMC article.

9

Zhang S, Wu J, Zhao Y, Zhang J, Zhang X, Wu C, Zhang Z, Guo Z. Zhang S, et al. Among authors: zhang j, zhang z, zhang x. Cancer Manag Res. 2024 Mar 14;16:151-161. doi: 10.2147/CMAR.S444916. eCollection 2024. Cancer Manag Res. 2024. PMID: 38501053 Free PMC article.

10

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis.

Zhao Y, Song R, Jia Y, Zhang X, Zhang S, Wu C, Zhang R, Guo Z. Zhao Y, et al. Among authors: zhang r, zhang s, zhang x. Curr Oncol. 2022 Sep 16;29(9):6610-6627. doi: 10.3390/curroncol29090519. Curr Oncol. 2022. PMID: 36135088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,402 results

Search Page

Filters